CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...
Phase 3
Barcelona, Spain and 83 other locations
in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...
Phase 3
Barcelona, Spain and 86 other locations
compared with placebo in participants with moderate-to-severe asthma.Study details include:* The study duration for each participant will be...
Phase 2
Barcelona, Spain and 25 other locations
12 years old with moderate to severe asthma....
Phase 2
Barcelona, Catalunya, Spain and 22 other locations
study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...
Phase 4
Barcelona, Spain and 64 other locations
is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...
Phase 3
Barcelona, Spain and 252 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Barcelona, Spain and 122 other locations
to budesonide in children from 6 to less than 12 years of age with asthma.* The study duration will be up to 37 weeks including an investiga...
Phase 3
Barcelona, Catalunya, Spain and 55 other locations
This study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated w...
Phase 3
Barcelona, Spain and 134 other locations
BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontrolled moderate-to-severe asthma...
Phase 2
Barcelona, Spain and 125 other locations
Clinical trials
Research sites
Resources
Legal